BrightBid Group AB (publ) (PERP-B) - Net Assets
Based on the latest financial reports, BrightBid Group AB (publ) (PERP-B) has net assets worth Skr28.54 Million SEK (≈ $3.07 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr58.98 Million ≈ $6.35 Million USD) and total liabilities (Skr30.44 Million ≈ $3.28 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See PERP-B net asset quality score to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr28.54 Million |
| % of Total Assets | 48.39% |
| Annual Growth Rate | 16.87% |
| 5-Year Change | 47.72% |
| 10-Year Change | 2235.23% |
| Growth Volatility | 205.4 |
BrightBid Group AB (publ) - Net Assets Trend (2012–2025)
This chart illustrates how BrightBid Group AB (publ)'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see PERP-B stock market capitalisation.
Annual Net Assets for BrightBid Group AB (publ) (2012–2025)
The table below shows the annual net assets of BrightBid Group AB (publ) from 2012 to 2025. Also explore PERP-B net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr30.77 Million ≈ $3.31 Million |
+183.22% |
| 2024-12-31 | Skr10.87 Million ≈ $1.17 Million |
+34.63% |
| 2023-12-31 | Skr8.07 Million ≈ $868.57K |
-42.48% |
| 2022-12-31 | Skr14.03 Million ≈ $1.51 Million |
-32.65% |
| 2021-12-31 | Skr20.83 Million ≈ $2.24 Million |
+39.18% |
| 2020-12-31 | Skr14.97 Million ≈ $1.61 Million |
-12.10% |
| 2019-12-31 | Skr17.03 Million ≈ $1.83 Million |
+24.07% |
| 2018-12-31 | Skr13.72 Million ≈ $1.48 Million |
+22.10% |
| 2017-12-31 | Skr11.24 Million ≈ $1.21 Million |
+752.96% |
| 2016-12-31 | Skr1.32 Million ≈ $141.82K |
-76.18% |
| 2015-12-31 | Skr5.53 Million ≈ $595.30K |
-9.67% |
| 2014-12-31 | Skr6.12 Million ≈ $659.05K |
+45.47% |
| 2013-12-31 | Skr4.21 Million ≈ $453.06K |
+3.77% |
| 2012-12-31 | Skr4.06 Million ≈ $436.60K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BrightBid Group AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr1.08 Million | 5.49% |
| Other Components | Skr18.68 Million | 94.51% |
| Total Equity | Skr19.76 Million | 100.00% |
BrightBid Group AB (publ) Competitors by Market Cap
The table below lists competitors of BrightBid Group AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NT Minerals Ltd
AU:NTM
|
$2.57 Million |
|
VCI Global Limited Ordinary Share
NASDAQ:VCIG
|
$2.57 Million |
|
Afentra PLC
LSE:AET
|
$2.58 Million |
|
Arkha Jayanti Persada PT
JK:ARKA
|
$2.58 Million |
|
Foresight VCT PLC
LSE:FTV
|
$2.57 Million |
|
Ramsdens Holdings PLC
LSE:RFX
|
$2.57 Million |
|
Northern Lion Gold Corp
V:NL
|
$2.56 Million |
|
Dolfines SAS
PA:ALDOL
|
$2.56 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BrightBid Group AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 7,845,898 to 19,762,000, a change of 11,916,102 (151.9%).
- Net income of 2,452,000 contributed positively to equity growth.
- Other factors increased equity by 9,464,102.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr2.45 Million | +12.41% |
| Other Changes | Skr9.46 Million | +47.89% |
| Total Change | Skr- | 151.88% |
Book Value vs Market Value Analysis
This analysis compares BrightBid Group AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.66x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.18x to 0.66x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Skr15.64 | Skr2.79 | x |
| 2013-12-31 | Skr12.56 | Skr2.79 | x |
| 2014-12-31 | Skr18.27 | Skr2.79 | x |
| 2015-12-31 | Skr2.95 | Skr2.79 | x |
| 2016-12-31 | Skr0.65 | Skr2.79 | x |
| 2017-12-31 | Skr3.92 | Skr2.79 | x |
| 2018-12-31 | Skr1.99 | Skr2.79 | x |
| 2019-12-31 | Skr1.58 | Skr2.79 | x |
| 2020-12-31 | Skr1.06 | Skr2.79 | x |
| 2021-12-31 | Skr1.08 | Skr2.79 | x |
| 2022-12-31 | Skr0.80 | Skr2.79 | x |
| 2023-12-31 | Skr0.49 | Skr2.79 | x |
| 2024-12-31 | Skr1.74 | Skr2.79 | x |
| 2025-12-31 | Skr4.24 | Skr2.79 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BrightBid Group AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.41%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.84%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 3.15x
- Recent ROE (12.41%) is above the historical average (-135.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -17.70% | -338.68% | 0.04x | 1.48x | Skr-1.12 Million |
| 2013 | -46.42% | -221.70% | 0.14x | 1.49x | Skr-1.84 Million |
| 2014 | -17.26% | -104.04% | 0.13x | 1.26x | Skr-1.67 Million |
| 2015 | -135.02% | -3083.76% | 0.03x | 1.35x | Skr-8.02 Million |
| 2016 | -852.70% | -80459.69% | 0.00x | 4.65x | Skr-11.37 Million |
| 2017 | -88.47% | -1245.60% | 0.05x | 1.37x | Skr-11.07 Million |
| 2018 | -90.24% | -1196.62% | 0.06x | 1.30x | Skr-13.76 Million |
| 2019 | -98.25% | -766.68% | 0.11x | 1.19x | Skr-18.43 Million |
| 2020 | -97.46% | -767.39% | 0.10x | 1.27x | Skr-16.08 Million |
| 2021 | -65.82% | -155.54% | 0.34x | 1.23x | Skr-15.80 Million |
| 2022 | -136.58% | -189.48% | 0.54x | 1.34x | Skr-20.57 Million |
| 2023 | -226.45% | -183.95% | 0.81x | 1.53x | Skr-19.08 Million |
| 2024 | -31.52% | -35.64% | 0.37x | 2.39x | Skr-3.26 Million |
| 2025 | 12.41% | 16.84% | 0.23x | 3.15x | Skr475.80K |
Industry Comparison
This section compares BrightBid Group AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $506,247,030
- Average return on equity (ROE) among peers: -29.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BrightBid Group AB (publ) (PERP-B) | Skr28.54 Million | -17.70% | 1.07x | $2.57 Million |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $177.99 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-132.02 Million | 0.00% | 0.00x | $11.08 Million |
| Aethlon Medical Inc (AEMD) | $4.89 Million | -146.36% | 0.30x | $1.02 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $903.35K |
| Adapthealth Corp (AHCO) | $245.55 Million | 0.85% | 0.03x | $800.36 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $6.89 Million | 30.07% | 0.49x | $4.97 Million |
| Allurion Technologies, Inc. (ALUR) | $-34.28 Million | 0.00% | 0.00x | $1.16 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $8.10 Million | -140.88% | 0.21x | $4.00 Million |
| Artivion Inc (AORT) | $7.30 Million | 9.59% | 0.70x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $9.29 Million | -10.75% | 0.15x | $126.79 Million |
About BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of dr… Read more